Oppenheimer analyst Silvan Tuerkcan raised the price target on Constellation Pharmaceuticals (NASDAQ: CNST) to $55.00 (from $40.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Constellation Pharmaceuticals (CNST) Prices 6.5M Share Common Offering at $34.50/ShDecember 11, 2019 5:57 AM Constellation Pharmaceuticals Announces Proposed Public Offering of Common StockDecember 9, 2019 4:19 PM Constellation Pharmaceuticals (CNST) Announces Proposed Public Offering of Common StockDecember 9, 2019 4:18 PM